XML 48 R36.htm IDEA: XBRL DOCUMENT v3.21.2
SCHEDULE OF BUSINESS INTERESTS INTO REPORTABLE SEGMENTS (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Segment Reporting Information [Line Items]        
Revenue $ 2,550,046 $ 6,332,269 $ 7,501,535 $ 15,128,226
Gross Profit 1,281,041 1,929,302 3,505,743 5,574,210
Segment Assets 5,514,101 11,854,011 5,514,101 11,854,011
Segment Profit (Loss)     (4,531,543) (223,893)
Trxade, Inc. [Member]        
Segment Reporting Information [Line Items]        
Revenue     3,653,269 4,268,619
Gross Profit     3,652,015 4,268,619
Segment Assets 1,487,657 1,828,345 1,487,657 1,828,345
Segment Profit (Loss)     1,511,809 2,655,734
Community Specialty Pharmacy, LLC [Member]        
Segment Reporting Information [Line Items]        
Revenue     1,287,296 1,287,197
Gross Profit     123,470 119,946
Segment Assets (404,174) 257,495 (404,174) 257,495
Segment Profit (Loss)     (89,025) (88,756)
Integra Pharma, LLC [Member]        
Segment Reporting Information [Line Items]        
Revenue     2,511,270 9,548,512
Gross Profit     (319,104) 1,162,030
Segment Assets 563,396 3,118,945 563,396 3,118,945
Segment Profit (Loss)     (2,500,032) 762,149
Other Segments [Member]        
Segment Reporting Information [Line Items]        
Revenue     49,700 23,898
Gross Profit     49,362 23,615
Segment Assets $ 3,867,221 $ 6,649,226 3,867,221 6,649,226
Segment Profit (Loss)     $ (3,454,295) $ (3,553,020)